133 related articles for article (PubMed ID: 38149553)
41. Ancient DNA analysis - An established technique in charting the evolution of tuberculosis and leprosy.
Donoghue HD; Spigelman M; O'Grady J; Szikossy I; Pap I; Lee OY; Wu HH; Besra GS; Minnikin DE
Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S140-4. PubMed ID: 25773651
[TBL] [Abstract][Full Text] [Related]
42. The spectrum of tuberculosis and leprosy: what can be the significance of specific humoral responses?
David HL
Res Microbiol; 1990 Feb; 141(2):197-206; discussion 263-5. PubMed ID: 2111921
[No Abstract] [Full Text] [Related]
43. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis.
Krenzien HN
Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341
[No Abstract] [Full Text] [Related]
44. Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment.
Branagan P; Moran B; Fitzgibbon M; Reid V; McMenamin M; Kane M; Kelly F; Barnes L; McLaughlin A; Keane J
Int J Tuberc Lung Dis; 2016 May; 20(5):706-8. PubMed ID: 27084829
[TBL] [Abstract][Full Text] [Related]
45. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
46. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries.
Han XY; Aung FM; Choon SE; Werner B
Am J Clin Pathol; 2014 Oct; 142(4):524-32. PubMed ID: 25239420
[TBL] [Abstract][Full Text] [Related]
48. Hansen's disease (leprosy) complicated by secondary mycobacterial infection.
Scollard DM; Stryjewska BM; Prestigiacomo JF; Gillis TP; Waguespack-Labiche J
J Am Acad Dermatol; 2011 Mar; 64(3):593-6. PubMed ID: 20494478
[TBL] [Abstract][Full Text] [Related]
49. Serologic response to mycobacterial proteins in hansen's patients during multidrug treatment.
Rada E; Aranzazu N; Ulrich M; Convit J
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):414-21. PubMed ID: 10700916
[TBL] [Abstract][Full Text] [Related]
50. Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.
Trindade MÂ; Miyamoto D; Benard G; Sakai-Valente NY; Vasconcelos Dde M; Naafs B
Am J Trop Med Hyg; 2013 Feb; 88(2):236-40. PubMed ID: 23208884
[TBL] [Abstract][Full Text] [Related]
51. Quantiferon-Gold Tuberculosis Test Cannot Detect Latent Tuberculosis in Patients With Leprosy.
Rendini T; Levis W
Clin Infect Dis; 2015 Nov; 61(9):1439-40. PubMed ID: 26209684
[TBL] [Abstract][Full Text] [Related]
52. The treatment of tuberculosis and leprosy.
Ellard GA
Lepr Rev; 1975 Sep; 46(3):149-55. PubMed ID: 1102829
[No Abstract] [Full Text] [Related]
53. Major proteins of mycobacterial strain ICRC and Mycobacterium leprae, identified by antibodies in sera from leprosy patients and their contacts.
Chiplunkar SV; Kudalkar JL; Butlin R; Samson PD; Deo MG; Gangal SG
J Clin Microbiol; 1992 Feb; 30(2):336-41. PubMed ID: 1537902
[TBL] [Abstract][Full Text] [Related]
54. Molecular and immunological characterization of the highly conserved antigen 84 from Mycobacterium tuberculosis and Mycobacterium leprae.
Hermans PW; Abebe F; Kuteyi VI; Kolk AH; Thole JE; Harboe M
Infect Immun; 1995 Mar; 63(3):954-60. PubMed ID: 7868268
[TBL] [Abstract][Full Text] [Related]
55. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
56. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
57. The association of leprosy and pulmonary tuberculosis.
Nigam P; Dubey AL; Dayal SG; Goyal BM; Saxena HN; Samuel KC
Lepr India; 1979 Jan; 51(1):65-73. PubMed ID: 449287
[TBL] [Abstract][Full Text] [Related]
58. Serological responses of patients with lepromatous and tuberculoid leprosy to 30-, 31-, and 32-kilodalton antigens of Mycobacterium tuberculosis.
Rumschlag HS; Shinnick TM; Cohen ML
J Clin Microbiol; 1988 Oct; 26(10):2200-2. PubMed ID: 3141462
[TBL] [Abstract][Full Text] [Related]
59. The difficulty in diagnosis and treatment of leprosy.
Forno C; Häusermann P; Hatz C; Itin P; Blum J
J Travel Med; 2010; 17(4):281-3. PubMed ID: 20636605
[TBL] [Abstract][Full Text] [Related]
60. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
